Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Nd-12

Phase 1

TThe Second Hospital of Nanjing Medical University

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q3 2028

Phase 1Recruiting

Diarrhea

NCT07767370

Clinical

Trials by Indication[1]

Diarrhea1 trial

A Randomised, Controlled, Double-blind Exploratory Study of ND-12 Combined With H-6 in the Treatment of Adult Chronic Inflammatory Diarrhea

Recruiting·TThe Second Hospital of Nanjing Medical University·Phase 1·NCT07767370·36 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Nd-12. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Nd-12. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — The Second Hospital of Nanjing Medical University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 1[1]
Company: TThe Second Hospital of Nanjing Medical University

Related News